PRL and neoplasm: At present, the treatment of PRL remains controversial, and consensus guidelines recommend dopamine agonists (DAs) as first-line treatments [21, 22], and surgery is indicated in patients who are resistant to DAs or cannot tolerate the side effects, or in cases of cystic fibroadenoma and persistent tumor bleeding with visual impairment [23–27].